Wave Life Sciences (WVE) Depreciation & Amortization (CF) (2014 - 2016)

Wave Life Sciences (WVE) has 13 years of Depreciation & Amortization (CF) data on file, last reported at $858000.0 in Q2 2026.

• Quarterly Depreciation & Amortization (CF) fell 0.81% year-over-year to $858000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.4 million (down 5.56% YoY) and the FY2025 annual result came in at $3.4 million, down 11.79% from the prior year.
• Depreciation & Amortization (CF) advanced to $858000.0 in Q2 2026, from $841000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.7 million in Q1 2022 to a low of $841000.0 in Q1 2026.
• A 5-year average of $1.1 million and a median of $1.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) decreased 29.71% — and 2026, when it dropped 0.81%.
• Tracing WVE's Depreciation & Amortization (CF) over 5 years: stood at $1.5 million in 2022, then declined by 29.71% to $1.1 million in 2023, then fell by 15.73% to $911000.0 in 2024, then dropped by 7.35% to $844000.0 in 2025, then increased by 1.66% to $858000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $858000.0 (Q2 2026), $841000.0 (Q1 2026), and $844000.0 (Q4 2025), per Business Quant data.